Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Parasitic Diseases

  Free Subscription


Articles published in Clin Infect Dis

Retrieve available abstracts of 31 articles:
HTML format



Single Articles


    September 2021
  1. OUATTARA M, Bassa FK, Diakite NR, Hattendorf J, et al
    Effectiveness of Four Different Interventions against Schistosoma haematobium in a Seasonal Transmission Setting of Cote d'Ivoire: A Cluster Randomized Trial.
    Clin Infect Dis. 2021 Sep 14. pii: 6369964. doi: 10.1093.
    PubMed     Abstract available


    August 2021
  2. SCHMITT EK, Ndayisaba G, Yeka A, Asante KP, et al
    Efficacy of cipargamin (KAE609) in a randomized, Phase II dose-escalation study in adults in sub-Saharan Africa with uncomplicated Plasmodium falciparum malaria.
    Clin Infect Dis. 2021 Aug 19. pii: 6354946. doi: 10.1093.
    PubMed     Abstract available


  3. CLARK J, Arinaitwe M, Nankasi A, Faust CL, et al
    Reconciling egg- and antigen-based estimates of Schistosoma mansoni clearance and reinfection: a modelling study.
    Clin Infect Dis. 2021 Aug 6. pii: 6343396. doi: 10.1093.
    PubMed     Abstract available


    July 2021
  4. FAN H, Gai W, Zhang L, Ma Y, et al
    Parasite Circulating Cell-free DNA in the Blood of Alveolar Echinococcosis Patients as a Diagnostic and Treatment-Status Indicator.
    Clin Infect Dis. 2021;73:e246-e251.
    PubMed     Abstract available


    May 2021
  5. KAMRAN M, Ejazi SA, Choudhury ST, Bhattacharyya A, et al
    A novel antigen, otubain cysteine peptidase of Leishmania donovani improves serodiagnosis of visceral leishmaniasis and monitors treatment response.
    Clin Infect Dis. 2021 May 13. pii: 6275590. doi: 10.1093.
    PubMed     Abstract available


    April 2021
  6. AYABINA D, Kura K, Toor J, Graham M, et al
    Maintaining low prevalence of Schistosoma mansoni: modelling the effect of less frequent treatment.
    Clin Infect Dis. 2021 Apr 28. pii: 6256990. doi: 10.1093.
    PubMed     Abstract available


  7. COFFENG LE, Le Rutte EA, Munoz J, Adams E, et al
    Antibody and antigen prevalence as indicators of ongoing transmission or elimination of visceral leishmaniasis: a modelling study.
    Clin Infect Dis. 2021 Apr 27. pii: 6255961. doi: 10.1093.
    PubMed     Abstract available


  8. COFFENG LE, Levecke B, Hattendorf J, Walker M, et al
    Survey design to monitor drug efficacy for the control of soil-transmitted helminthiasis and schistosomiasis.
    Clin Infect Dis. 2021 Apr 27. pii: 6255959. doi: 10.1093.
    PubMed     Abstract available


  9. SUMNER KM, Freedman E, Mangeni JN, Obala AA, et al
    Exposure to diverse Plasmodium falciparum genotypes shapes the risk of symptomatic malaria in incident and persistent infections: A longitudinal molecular epidemiologic study in Kenya.
    Clin Infect Dis. 2021 Apr 27. pii: 6255633. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  10. LAGO T, Carvalho L, Nascimento M, Guimaraes LH, et al
    Influence of Obesity on Clinical Manifestations and Response to Therapy in Cutaneous Leishmaniasis caused by Leishmania braziliensis.
    Clin Infect Dis. 2021 Mar 16. pii: 6174316. doi: 10.1093.
    PubMed     Abstract available


  11. NIANG M, Sandfort M, Mbodj AF, Diouf B, et al
    Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions.
    Clin Infect Dis. 2021 Mar 2. pii: 6157008. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  12. VERREST L, Kip AE, Musa A, Schoone GJ, et al
    Blood parasite load as an early marker to predict treatment response in visceral leishmaniasis in Eastern Africa.
    Clin Infect Dis. 2021 Feb 13. pii: 6134305. doi: 10.1093.
    PubMed     Abstract available


    January 2021
  13. MISCHLINGER J, Dudek V, Ramharter M
    Predictive performance of rapid diagnostic tests for falciparum malaria and its modelled impact on integrated community case management of malaria in sub-Saharan African febrile children.
    Clin Infect Dis. 2021 Jan 28. pii: 6121687. doi: 10.1093/cid/ciaa1942.
    PubMed     Abstract available


    November 2020
  14. MITCHELL CL, Topazian HM, Brazeau NF, Deutsch-Feldman M, et al
    Household prevalence of P. falciparum, P. vivax, and P. ovale in the Democratic Republic of the Congo, 2013-2014.
    Clin Infect Dis. 2020 Nov 26. pii: 6006303. doi: 10.1093/cid/ciaa1772.
    PubMed     Abstract available


    October 2020
  15. SOTO JA, Berman JD
    Miltefosine treatment of Cutaneous Leishmaniasis.
    Clin Infect Dis. 2020 Oct 31. pii: 5944710. doi: 10.1093/cid/ciaa1461.
    PubMed    


  16. WARE JM, O'Connell EM, Brown T, Wetzler L, et al
    Efficacy and Tolerability of Miltefosine in the Treatment of Cutaneous Leishmaniasis.
    Clin Infect Dis. 2020 Oct 28. pii: 5943554. doi: 10.1093/cid/ciaa1238.
    PubMed     Abstract available


    September 2020
  17. LYKE KE, Singer A, Berry AA, Reyes S, et al
    Multidose Priming and Delayed Boosting Improve PfSPZ Vaccine Efficacy against Heterologous P. falciparum Controlled Human Malaria Infection.
    Clin Infect Dis. 2020 Sep 12. pii: 5904973. doi: 10.1093/cid/ciaa1294.
    PubMed     Abstract available


  18. HOUNKONNOU CPA, Ndam NT, Fievet N, Accrombessi M, et al
    Sub-optimal Intermittent Preventive Treatment in pregnancy (IPTp) is associated with an increased risk of submicroscopic P. falciparum infection in pregnant women: a prospective cohort study in Benin.
    Clin Infect Dis. 2020 Sep 9. pii: 5903262. doi: 10.1093/cid/ciaa1355.
    PubMed     Abstract available


  19. MACHADO PRL, Prates FVO, Boaventura V, Lago T, et al
    A double-bind and randomized trial to evaluate Miltefosine and topical GM-CSF in the treatment of cutaneous leishmaniasis caused by Leishmania braziliensis in Brazil.
    Clin Infect Dis. 2020 Sep 7. pii: 5902344. doi: 10.1093/cid/ciaa1337.
    PubMed     Abstract available


    August 2020
  20. CASTELLUCCI LC, Almeida L, Cherlin S, Fakiola M, et al
    A Genome-Wide Association Study Identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1 and KRT80 As Risk Loci Contributing to Cutaneous Leishmaniasis In Brazil.
    Clin Infect Dis. 2020 Aug 23. pii: 5896307. doi: 10.1093/cid/ciaa1230.
    PubMed     Abstract available


  21. POTVIN JE, Leprohon P, Queffeulou M, Sundar S, et al
    Mutations in an aquaglyceroporin as a proven marker of antimony clinical resistance in the parasite Leishmania donovani.
    Clin Infect Dis. 2020 Aug 22. pii: 5895967. doi: 10.1093/cid/ciaa1236.
    PubMed     Abstract available


  22. GOMEZ MA, Navas A, Prieto M, Giraldo-Parra L, et al
    Immuno-pharmacokinetics of meglumine antimoniate in patients with cutaneous leishmaniasis caused by Leishmania Viannia.
    Clin Infect Dis. 2020 Aug 20. pii: 5895071. doi: 10.1093/cid/ciaa1206.
    PubMed     Abstract available


  23. UYOGA S, Wanjiku P, Rop JC, Makale J, et al
    Plasma Plasmodium falciparum Histidine-Rich Protein-2 concentrations in children with malaria infections of differing severity in Kilifi, Kenya.
    Clin Infect Dis. 2020 Aug 9. pii: 5890098. doi: 10.1093/cid/ciaa1141.
    PubMed     Abstract available


    July 2020
  24. KUBLIN JG, Murphy SC, Maenza J, Seilie AM, et al
    Safety, pharmacokinetics and causal prophylactic efficacy of KAF156 in a Plasmodium falciparum human infection study.
    Clin Infect Dis. 2020 Jul 9. pii: 5869402. doi: 10.1093.
    PubMed     Abstract available


    June 2020
  25. JAFARI-GUEMOURI S, Courtois L, Mama A, Rouas B, et al
    A genotypical study in Benin comparing the carriage of P. falciparum infections before pregnancy and in the early pregnancy: story of a persistent infection.
    Clin Infect Dis. 2020 Jun 22. pii: 5860917. doi: 10.1093.
    PubMed     Abstract available


  26. BUNDI CK, Nalwoga A, Lubyayi L, Muriuki JM, et al
    Iron deficiency is associated with reduced levels of Plasmodium falciparum-specific antibodies in African children.
    Clin Infect Dis. 2020 Jun 7. pii: 5854375. doi: 10.1093.
    PubMed     Abstract available


    May 2020
  27. MAIRET-KHEDIM M, Leang R, Marmai C, Khim N, et al
    Clinical and in vitro resistance of Plasmodium falciparum to artesunate-amodiaquine in Cambodia.
    Clin Infect Dis. 2020 May 27. pii: 5847731. doi: 10.1093.
    PubMed     Abstract available


    March 2020
  28. CNOPS L, Huyse T, Maniewski U, Soentjens P, et al
    Acute Schistosomiasis with A S. Mattheei x S. Haematobium Hybrid Species in a Cluster of 34 Travelers Infected in South Africa.
    Clin Infect Dis. 2020 Mar 26. pii: 5812135. doi: 10.1093.
    PubMed     Abstract available


  29. STOTHARD R, Webster BL
    Acute schistosomiasis: Which molecular diagnostic test is best and why.
    Clin Infect Dis. 2020 Mar 26. pii: 5812133. doi: 10.1093.
    PubMed    


    September 2019
  30. STEINHARDT LC, Richie TL, Yego R, Akach D, et al
    Safety, tolerability, and immunogenicity of PfSPZ Vaccine administered by direct venous inoculation to infants and young children: findings from an age de-escalation, dose-escalation double-blinded randomized, controlled study in western Kenya.
    Clin Infect Dis. 2019 Sep 26. pii: 5573993. doi: 10.1093.
    PubMed     Abstract available


  31. HOUNKONNOU CPA, Briand V, Fievet N, Accrombessi M, et al
    Dynamics of Submicroscopic Plasmodium falciparum Infections Throughout Pregnancy: A Preconception Cohort Study in Benin.
    Clin Infect Dis. 2019 Sep 12. pii: 5563807. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parasitic Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: